• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM 3MAX REPERFUSION CATHETER; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM 3MAX REPERFUSION CATHETER; NRY Back to Search Results
Catalog Number 3MAXC
Device Problems Fracture (1260); Physical Resistance (2578); Patient-Device Incompatibility (2682)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/18/2017
Event Type  malfunction  
Manufacturer Narrative
Results: the penumbra system 3max reperfusion catheter (3max) was fractured approximately 141.0 cm from the hub.Conclusions: evaluation of the device revealed a fracture on the distal region of the catheter shaft.This type of damage may result from retracting the catheter against strong resistance.The excessively calcified clot may have pinned the catheter inside the anatomy resulting in the resistance felt by the physician when retracting the catheter and ultimately the 3max fracture.Penumbra catheters are inspected during in-process inspection and during quality inspection after manufacturing.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.
 
Event Description
The patient was undergoing a thrombectomy procedure to treat a cardiogenic cerebral infarction in the m1 segment of the middle cerebral artery (mca) using a penumbra system 3max reperfusion catheter (3max).During the procedure, the physician coaxially advanced a penumbra system 5max ace reperfusion catheter (5max ace) and the 3max through a balloon guiding catheter to the target vessel.After successfully completing the first pass using the adapt technique, the 3max was removed.While attempting to re-insert the 3max into the 5max ace, the physician noticed that the 3max was fractured at the mid-shaft.The physician believes that the 3maxc was damaged when advancing it forcefully around the internal carotid artery (ica), which was confirmed to have excessive calcification.In addition, the physician experienced a slight resistance when retracting the 3max and the physician believed that it is possible that the fracture might have occurred during the removal process.The 3max was set aside and the procedure was completed using a new 3max and the same 5max ace.There was no report of an adverse effect to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM 3MAX REPERFUSION CATHETER
Type of Device
NRY
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key6439853
MDR Text Key71052986
Report Number3005168196-2017-00468
Device Sequence Number1
Product Code NRY
UDI-Device Identifier00814548012490
UDI-Public00814548012490
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K160449
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/26/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/28/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date08/15/2019
Device Catalogue Number3MAXC
Device Lot NumberF71103
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/17/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/26/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/15/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age73 YR
-
-